Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
59.9K
-
Shares change
-
-15.5K
-
Total reported value, excl. options
-
$880K
-
Value change
-
-$123K
-
Number of buys
-
3
-
Number of sells
-
-5
-
Price
-
$14.43
Significant Holders of EXOZYMES INC. - COM (EXOZ) as of Q3 2025
9 filings reported holding EXOZ - EXOZYMES INC. - COM as of Q3 2025.
EXOZYMES INC. - COM (EXOZ) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59.9K shares
.
Largest 9 shareholders include VANGUARD GROUP INC (26K shares), GEODE CAPITAL MANAGEMENT, LLC (23.1K shares), BlackRock, Inc. (4.99K shares), UBS Group AG (4.62K shares), MORGAN STANLEY (1.25K shares), BANK OF AMERICA CORP /DE/ (23 shares), RAYMOND JAMES FINANCIAL INC (0 shares), CITADEL ADVISORS LLC (0 shares), and Tower Research Capital LLC (TRC) (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.